Effects of late evening snack on diurnal plasma glucose profile in patients with chronic viral liver disease

Hepatology Research

Volumn 40, Issue 9, 2010, Pages 887-893

  Suzuki, Kazutomo ^a   Kagawa, Kagemasa ^a   Koizumi, Kazuhito ^a   Suzuki, Kazuyoshi ^a   Katayama, Hiromi ^a   Sugawara, Miwa ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic liver disease; Diabetes; Late evening snack; Plasma glucose

Indexed keywords

C PEPTIDE; GLUCOSE;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; INSULIN RESISTANCE; LATE EVENING SNACK; LIVER CIRRHOSIS; MALE; MEAL; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 77956137277     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00691.x     Document Type: Article

References (15)

1. EL-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004, 126:460-8.
2. Tazawa J, Maeda M, Nakagawa M. Diabetes Mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 2002, 47:710-5.
3. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994, 20:119-25.
4. Kwon SY, Kim SS, Kwon OS. Prognostic significance of glecaemic control in patients with HBV and HCV-related cirrhosis and diabetes. Diabet Med 2005, 22:1530-85.
5. Swart GR, Zillikens MC, van Vuure JK, van den Berg JWO. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989, 299:1202-3.
6. Board of directors and the clinical guidelines task force: guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr 2002, 26(Suppl 1):1SA-138SA. A.S.P.E.N.
7. Plauth M, Merli M, Kondrup J. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997, 16:43-55.
8. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-9.
9. Muto Y, Sato S, Watanabe A. Overweight and obesity increase the risk for liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006, 35:204-14.
10. Hui JM, Sud A, Farrell GC. Insulin Resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003, 125:1695-704.
11. EI-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 2001, 96:2462-7.
12. Saito K, Inoue S, Saito T. Augmentation effect of postprandial hyperinsulinemia on growth of human hepatocellular carcinoma. Gut 2002, 51:100-4.
13. Komura T, Mizukoshi E, Kita Y. Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol 2007, 102:1939-46.
14. Yamashita S, Suzuki C, Tanigawa K, Sakaida I, Okita K. Glucose utilization after administration of glucose in patients with cirrhosis. Kanzo 1999, 40:636-44.
15. Sotaniemi EA, Keinänen K, Lahtela JT, Kairaluoma M. Carbohydrate intolerance associated with reduced hepatic glucose phosphorylating and releasing enzyme activities and peripheral insulin resistance in alcoholics with liver cirrhosis. J Hepatol 1985, 1:277-90.